Smokeless Tobacco Use Clinical Trial
Official title:
QuitSpit: An Internet-Based Smokeless Tobacco Cessation Program for Teens
Verified date | September 2012 |
Source | Oregon Research Institute |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Interventional |
To compare the efficacy of a targeted, tailored, and highly interactive smokeless tobacco cessation website to a website with more static information that is similar to websites that can be found through a typical Internet search.
Status | Completed |
Enrollment | 1716 |
Est. completion date | March 2012 |
Est. primary completion date | March 2012 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 14 Years to 25 Years |
Eligibility |
Inclusion Criteria: - 14-25 years of age - Have access to the Internet - Currently using smokeless tobacco products - Currently contemplating quitting all tobacco products - Able to read and write English; and - Willing to share phone number, e-mail, and mailing address with the research project |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United States | Oregon Research Institute | Eugene | Oregon |
Lead Sponsor | Collaborator |
---|---|
Oregon Research Institute |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Abstinence from all tobacco | 3 months and 6 months | No | |
Primary | Abstinence from smokeless tobacco | 3 months and 6 months | No | |
Secondary | Evaluate the relative effectiveness of the two programs on secondary outcomes, including reduction in smokeless tobacco use, number of quit attempts, and confidence in quitting. | 3 months and 6 months | No | |
Secondary | Identify participant characteristics, including demographic characteristics, initial smokeless tobacco use and dependence, and patterns of program use that predict treatment outcomes. | 3 months and 6 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00939029 -
Highdose Nicotine Patch Therapy for Smokeless Tobacco Use
|
Phase 2/Phase 3 | |
Completed |
NCT00392379 -
Nicotine Lozenges for Treatment of Smokeless Tobacco Addiction
|
Phase 3 | |
Completed |
NCT01067586 -
Novel Determinants and Measures of Smokeless Tobacco Use: Study 1
|
||
Completed |
NCT00888459 -
A Pilot Study Evaluating Nicotine Lozenges and Self Help
|
Phase 2 |